Different functional basal ganglia subcircuits associated with anti-akinetic and dyskinesiogenic effects of antiparkinsonian therapies

Neurobiology of Disease

Volumn 36, Issue 1, 2009, Pages 116-125

  Lacombe, Emilie ^a   Khaindrava, Vitaly ^a,b   Melon, Christophe ^a   Oueslati, Abid ^a   Kerkerian Le Goff, Lydia ^a   Salin, Pascal ^a  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b P K ANOKHIN INSTITUTE OF NORMAL PHYSIOLOGY   (Russian Federation)

Author keywords

6 hydroxydopamine; Basal ganglia; Cytochrome oxidase; Dyskinesias; High frequency stimulation; l DOPA; Parkinson's disease; Preprodynorphin; Rat; Subthalamic nucleus

Indexed keywords

BENSERAZIDE; CYTOCHROME C OXIDASE; LEVODOPA; MESSENGER RNA; PREPRODYNORPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFICACY; DYSKINESIA; ENTOPEDUNCULAR NUCLEUS; GENE EXPRESSION; GLOBUS PALLIDUS; MALE; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; THERAPY EFFECT;

ANIMALS; ANTIPARKINSON AGENTS; BASAL GANGLIA; DISEASE MODELS, ANIMAL; DYNORPHINS; DYSKINESIA, DRUG-INDUCED; ELECTRIC STIMULATION; ELECTRODES, IMPLANTED; ELECTRON TRANSPORT COMPLEX IV; GENE EXPRESSION REGULATION; LEVODOPA; MALE; NERVE NET; OXIDOPAMINE; PARKINSONIAN DISORDERS; PROTEIN PRECURSORS; PROTEIN SUBUNITS; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 69949103579     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.07.002     Document Type: Article

References (68)

1. Alonso-Frech F., Zamarbide I., Alegre M., Rodríguez-Oroz M.C., Guridi J., Manrique M., Valencia M., Artieda J., and Obeso J.A. Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease. Brain 129 (2006) 1748-1757
2. Andersson M., Hilbertson A., and Cenci M.A. Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease. Neurobiol. Dis. 6 (1999) 461-474
3. Aubert I., Guigoni C., Li Q., Dovero S., Bioulac B.H., Gross C.E., Crossman A.R., Bloch B., and Bezard E. Enhanced preproenkephalin-B-derived opioid transmission in striatum and subthalamic nucleus converges upon globus pallidus internalis in l-3,4-dihydroxyphenylalanine-induced dyskinesia. Biol. Psychiatry 61 (2007) 836-844
4. Bacci J.J., Absi e.H., Manrique C., Baunez C., Salin P., and Kerkerian-LeGoff L. Differential effects of prolonged high frequency stimulation and of excitotoxic lesion of the subthalamic nucleus on dopamine denervation-induced cellular defects in the rat striatum and globus pallidus. Eur. J. Neurosci. 20 (2004) 3331-3341
5. Baunez C., and Amalric M. Evidence for functional differences between entopeduncular nucleus and substantia nigra: effects of APV (dl-2-amino-5-phosphonovaleric acid) microinfusion on reaction time performance in the rat. Eur. J. Neurosci. 8 (1996) 1972-1982
6. Bejjani B., Damier P., Arnulf I., Bonnet A.M., Vidailhet M., Dormont D., Pidoux B., Cornu P., Marsault C., and Agid Y. Pallidal stimulation for Parkinson's disease. Two targets. Neurology 49 (1997) 1564-1569
7. Benabid A.L., Pollak P., Gross C., Hoffmann D., Benazzouz A., Gao D.M., Laurent A., Gentil M., and Perret J. Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotact. Funct. Neurosurg. 62 (1994) 76-84
8. Benabid A.L., Chabardes S., Mitrofanis J., and Pollak P. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol. 8 (2009) 67-81
9. Boraud T., Bezard E., Guehl D., Bioulac B., and Gross C. Effects of l-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkey. Brain Res. 787 (1998) 157-160
10. Boraud T., Bezard E., Bioulac B., and Gross C.E. Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey. Brain 124 (2001) 546-557
11. Boulet S., Lacombe E., Carcenac C., Feuerstein C., Sgambato-Faure V., Poupard A., and Savasta M. Subthalamic stimulation-induced forelimb dyskinesias are linked to an increase in glutamate levels in the substantia nigra pars reticulata. J. Neurosci. 26 (2006) 10768-10776
12. Breysse N., Amalric M., and Salin P. Metabotropic glutamate 5 receptor blockade alleviates akinesia by normalizing activity of selective basal-ganglia structures in parkinsonian rats. J. Neurosci. 23 (2003) 8302-8309
13. Burbaud P., Bonnet B., Guehl D., Lagueny A., and Bioulac B. Movement disorders induced by gamma-aminobutyric agonist and antagonist injections into the internal globus pallidus and substantia nigra pars reticulata of the monkey. Brain Res. 780 (1998) 102-107
14. Canales J.J., Gilmour G., and Iversen S.D. The role of nigral and thalamic output pathways in the expression of oral stereotypes induced by amphetamine injections into the striatum. Brain Res. 856 (2000) 176-183
15. Cenci M.A. Dopamine dysregulation of movement control in l-DOPA-induced dyskinesia. Trends Neurosci. 30 (2007) 236-243
16. Cenci M.A., and Lundblad M. Post-versus presynaptic plasticity in l-DOPA-induced dyskinesia. J. Neurochem. 99 (2006) 381-392
17. Cenci M.A., Lee C.S., and Bjorklund A. l-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin-and glutamic acid decarboxylase mRNA. Eur. J. Neurosci. 10 (1998) 2694-2706
18. Chen L., Togasaki D.M., Langston J.W., Di Monte D.A., and Quik M. Enhanced striatal opioid receptor-mediated G-protein activation in l-DOPA-treated dyskinetic monkeys. Neuroscience 132 (2005) 409-420
19. Civelli O., Douglass J., Goldstein A., and Herbert E. Sequence and expression of the rat prodynorphin gene. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 4291-4295
20. Degos B., Deniau J.M., Thierry A.M., Glowinski J., Pezard L., and Maurice N. Neuroleptic-induced catalepsy: electrophysiological mechanisms of functional recovery induced by high-frequency stimulation of the subthalamic nucleus. J. Neurosci. 25 (2005) 7687-7696
21. deGroot J. The Rat Forebrain in Stereotaxic Coordinates (1959), Amsterdam
22. DeLong M.R., Crutcher M.D., and Georgopoulos A.P. Relations between movement and single cell discharge in the substantia nigra of the behaving monkey. J. Neurosci. 3 (1983) 1599-1606
23. Deniau J.M., Menetrey A., and Charpier S. The lamellar organization of the rat substantia nigra pars reticulata: segregated patterns of striatal afferents and relationship to the topography of corticostriatal projections. Neuroscience 73 (1996) 761-781
24. Follett K.A. Comparison of pallidal and subthalamic deep brain stimulation for the treatment of levodopa-induced dyskinesias. Neurosurg. Focus. 17 (2004) E3
25. Gadaleta G., Pepe G., De C.G., Quagliariello C., Sbisa E., and Saccone C. The complete nucleotide sequence of the Rattus norvegicus mitochondrial genome: cryptic signals revealed by comparative analysis between vertebrates. J. Mol. Evol. 28 (1989) 497-516
26. Garcia L., D'Alessandro G., Bioulac B., and Hammond C. High-frequency stimulation in Parkinson's disease: more or less?. Trends Neurosci. 28 (2005) 209-216
27. Gerfen C.R., and Young III W.S. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460 (1988) 161-167
28. Gradinaru V., Mogri M., Thompson K.R., Henderson J.M., and Deisseroth K. Optical deconstruction of parkinsonian neural circuitry. Science 324 (2009) 354-359
29. Gubellini P., Eusebio A., Oueslati A., Melon C., Kerkerian-Le G.L., and Salin P. Chronic high-frequency stimulation of the subthalamic nucleus and l-DOPA treatment in experimental parkinsonism: effects on motor behaviour and striatal glutamate transmission. Eur. J. Neurosci. 24 (2006) 1802-1814
30. Guridi J., Obeso J.A., Rodriguez-Oroz M.C., Lozano A.A., and Manrique M. l-DOPA-induced dyskinesia and stereotactic surgery for Parkinson's disease. Neurosurgery 62 (2008) 311-323
31. Henry B., Crossman A.R., and Brotchie J.M. Effect of repeated l-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat. Exp. Neurol. 155 (1999) 204-220
32. Henry B., Duty S., Fox S.H., Crossman A.R., and Brotchie J.M. Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease. Exp. Neurol. 183 (2003) 458-468
33. Hevner R.F., and Wong-Riley M.T. Regulation of cytochrome oxidase protein levels by functional activity in the macaque monkey visual system. J. Neurosci. 10 (1990) 1331-1340
34. Hevner R.F., and Wong-Riley M.T. Neuronal expression of nuclear and mitochondrial genes for cytochrome oxidase (CO) subunits analyzed by in situ hybridization: comparison with CO activity and protein. J. Neurosci. 11 (1991) 1942-1958
35. Hevner R.F., and Wong-Riley M.T. Mitochondrial and nuclear gene expression for cytochrome oxidase subunits are disproportionately regulated by functional activity in neurons. J. Neurosci. 13 (1993) 1805-1819
36. Johansson P.A., Andersson M., Andersson K.E., and Cenci M.A. Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia. Neurobiol. Dis. 8 (2001) 220-239
37. Katayama Y., Oshima H., Kano T., Kobayashi K., Fukaya C., and Yamamoto T. Direct effect of subthalamic nucleus stimulation on levodopa-induced peak-dose dyskinesia in patients with Parkinson's disease. Stereotact. Funct. Neurosurg. 84 (2006) 176-179
38. Kleiner-Fisman G., Fisman D.N., Sime E., Saint-Cyr J.A., Lozano A.M., and Lang A.E. Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. J. Neurosurg. 99 (2003) 489-495
39. Krack P., Fraix V., Mendes A., Benabid A.L., and Pollak P. Postoperative management of subthalamic nucleus stimulation for Parkinson's disease. Mov. Disord. 17 Suppl. 3 (2002) S188-S197
40. Krack P., Pollak P., Limousin P., Hoffmann D., Benazzouz A., Le Bas J.F., Koudsie A., and Benabid A.L. Opposite motor effects of pallidal stimulation in Parkinson's disease. Ann. Neurol. 43 (1998) 180-192
41. Lacombe E., Carcenac C., Boulet S., Feuerstein C., Bertrand A., Poupard A., and Savasta M. High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats. Eur. J. Neurosci. 26 (2007) 1670-1680
42. Lavin A., and Garcia-Munoz M. Electrophysiological changes in substantia nigra after dynorphin administration. Brain Res. 369 (1986) 298-302
43. McIntyre C.C., Savasta M., Kerkerian-Le G.L., and Vitek J.L. Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both. Clin. Neurophysiol. 115 (2004) 1239-1248
44. Meissner W., Leblois A., Hansel D., Bioulac B., Gross C.E., Benazzouz A., and Boraud T. Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations. Brain 128 (2005) 2372-2382
45. Meissner W., Guigoni C., Cirilli L., Garret M., Bioulac B.H., Gross C.E., Bezard E., and Benazzouz A. Impact of chronic subthalamic high-frequency stimulation on metabolic basal ganglia activity: a 2-deoxyglucose uptake and cytochrome oxidase mRNA study in a macaque model of Parkinson's disease. Eur. J. Neurosci. 25 (2007) 1492-1500
46. Meissner W., Ravenscroft P., Reese R., Harnack D., Morgenstern R., Kupsch A., Klitgaard H., Bioulac B., Gross C.E., Bezard E., and Boraud T. Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine. Neurobiol. Dis. 22 (2006) 586-598
47. Moro E., Scerrati M., Romito L.M., Roselli R., Tonali P., and Albanese A. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology 53 (1999) 85-90
48. Nevet A., Morris G., Saban G., Fainstein N., and Bergman H. Discharge rate of substantia nigra pars reticulata neurons is reduced in non-parkinsonian monkeys with apomorphine-induced orofacial dyskinesia. J. Neurophysiol. 92 (2004) 1973-1981
49. Nielsen K.M., and Soghomonian J.J. Dual effects of intermittent or continuous l-DOPA administration on gene expression in the globus pallidus and subthalamic nucleus of adult rats with a unilateral 6-OHDA lesion. Synapse 49 (2003) 246-260
50. Oueslati A., Breysse N., Amalric M., Kerkerian-Le G.L., and Salin P. Dysfunction of the cortico-basal ganglia-cortical loop in a rat model of early parkinsonism is reversed by metabotropic glutamate receptor 5 antagonism. Eur. J. Neurosci. 22 (2005) 2765-2774
51. Oueslati A., Sgambato-Faure V., Melon C., Kachidian P., Gubellini P., Amri M., Kerkerian-Le G.L., and Salin P. High-frequency stimulation of the subthalamic nucleus potentiates l-DOPA-induced neurochemical changes in the striatum in a rat model of Parkinson's disease. J. Neurosci. 27 (2007) 2377-2386
52. Pahwa R., Wilkinson S.B., Overman J., and Lyons K.E. Preoperative clinical predictors of response to bilateral subthalamic stimulation in patients with Parkinson's disease. Stereotact. Funct. Neurosurg. 83 (2005) 80-83
53. Paquet M., and Smith Y. Differential localization of AMPA glutamate receptor subunits in the two segments of the globus pallidus and the substantia nigra pars reticulata in the squirrel monkey. Eur. J. Neurosci. 8 (1996) 229-233
54. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. Second Ed. (1986) New York
55. Perier C., Marin C., Jimenez A., Bonastre M., Tolosa E., and Hirsch E.C. Effect of subthalamic nucleus or entopeduncular nucleus lesion on levodopa-induced neurochemical changes within the basal ganglia and on levodopa-induced motor alterations in 6-hydroxydopamine-lesioned rats. J. Neurochem. 86 (2003) 1328-1337
56. Perlmutter J.S., and Mink J.W. Deep brain stimulation. Annu. Rev. Neurosci. 29 (2006) 229-257
57. Pirker S., Schwarzer C., Wieselthaler A., Sieghart W., and Sperk G. GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 101 (2000) 815-850
58. Redgrave P., Dean P., Donohoe T.P., and Pope S.G. Superior colliculus lesions selectively attenuate apomorphine-induced oral stereotypy: a possible role for the nigrotectal pathway. Brain Res. 196 (1980) 541-546
59. Russmann H., Ghika J., Combrement P., Villemure J.G., Bogousslavsky J., Burkhard P.R., and Vingerhoets F.J. l-DOPA-induced dyskinesia improvement after STN-DBS depends upon medication reduction. Neurology 63 (2004) 153-155
60. Salin P., Manrique C., Forni C., and Kerkerian-Le G.L. High-frequency stimulation of the subthalamic nucleus selectively reverses dopamine denervation-induced cellular defects in the output structures of the basal ganglia in the rat. J. Neurosci. 22 (2002) 5137-5148
61. Sestini S., Ramat S., Formiconi A.R., Ammannati F., Sorbi S., and Pupi A. Brain networks underlying the clinical effects of long-term subthalamic stimulation for Parkinson's disease: a 4-year follow-up study with rCBF SPECT. J. Nucl. Med. 46 (2005) 1444-1454
62. Tai C.H., Boraud T., Bezard E., Bioulac B., Gross C., and Benazzouz A. Electrophysiological and metabolic evidence that high-frequency stimulation of the subthalamic nucleus bridles neuronal activity in the subthalamic nucleus and the substantia nigra reticulata. FASEB J. 17 (2003) 1820-1830
63. Tel B.C., Zeng B.Y., Cannizzaro C., Pearce R.K., Rose S., and Jenner P. Alterations in striatal neuropeptide mRNA produced by repeated administration of l-DOPA, ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosets. Neuroscience 115 (2002) 1047-1058
64. Vila M., Levy R., Herrero M.T., Faucheux B., Obeso J.A., Agid Y., and Hirsch E.C. Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemistry study. Neuroscience 71 (1996) 903-912
65. Vila M., Levy R., Herrero M.T., Ruberg M., Faucheux B., Obeso J.A., Agid Y., and Hirsch E.C. Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA. J. Neurosci. 17 (1997) 765-773
66. Welter M.L., Houeto J.L., Tezenas du M.S., Mesnage V., Bonnet A.M., Pillon B., Arnulf I., Pidoux B., Dormont D., Cornu P., and Agid Y. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain 125 (2002) 575-583
67. Welter M.L., Houeto J.L., Bonnet A.M., Bejjani P.B., Mesnage V., Dormont D., Navarro S., Cornu P., Agid Y., and Pidoux B. Effects of high-frequency stimulation on subthalamic neuronal activity in parkinsonian patients. Arch. Neurol. 61 (2004) 89-96
68. Yelnik J., Damier P., Bejjani B.P., Francois C., Gervais D., Dormont D., Arnulf I., Bonnet M., Cornu P., Pidoux B., and Agid Y. Functional mapping of the human globus pallidus: contrasting effect of stimulation in the internal and external pallidum in Parkinson's disease. Neuroscience 101 (2000) 77-87